TriSalus Life Sciences, Inc. TLSI
3.48 USD -0.15 (-4.13%)
Nov 3, 2026, 3:22 PM EST
3.45 Day range 3.77
2.20 52-week range 7.95
- YTD
- -50.14%
- 1 year
- -26.11%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 45.15M | 29.43M | 18.51M | 12.40M | 8.40M | |
| 38.19M | 25.33M | 15.91M | 10.14M | 7.21M | |
| -26.95M | -36.16M | -54.48M | -36.86M | -23.29M | |
| -39.23M | -30.05M | -59.36M | -47.19M | -28.84M | |
| -1.84 | -1.31 | -6.77 | -161.55 | -131.65 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 20.44M | 8.53M | 11.78M | 9.41M | 30.30M | |
| 35.33M | 23.97M | 24.60M | 22.00M | 37.84M | |
| 69.19M | 49.87M | 51.66M | 34.32M | 6.93M | |
| 34.44M | 23.63M | 1.59M | 1.96M | 0 | |
| -33.86M | -25.89M | -27.07M | -176.33M | -129.60M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -18.01M | -40.84M | -50.58M | -32.31M | -22.70M | |
| -838.00K | -345.00K | -1.59M | -1.79M | -2.26M | |
| 30.76M | 37.94M | 54.63M | 13.46M | 50.77M | |
| -838.00K | -345.00K | -588.00K | -786.00K | -1.26M | |
| 11.91M | -3.25M | 2.46M | -20.64M | 25.81M |